Inventor · disambiguated record
Nathaniel Stephen Wang
Also filed as: WANG NATHANIEL S · WANG NATHANIEL STEPHEN
11 granted patents·14 pending applications·31 citations·filing 2017–2024
85Inventor score
Files withREPLICATE BIOSCIENCE INC13JANSSEN PHARMACEUTICALS INC9L LIVERMORE NAT SECURITY LLC2JANSSEN SCIENCES IRELAND UNLIMITED CO1
Top patents by PatentIndex Score
25 records- 0194US11083786B2Induce and enhance immune responses using recombinant replicon systemsJANSSEN PHARMACEUTICALS INC·Filed 2019·Granted Aug 10, 2021·13 cites·24 claims
- 0290US10538786B2Recombinant arterivirus replicon systems and uses thereofJANSSEN PHARMACEUTICALS INC·Filed 2017·Granted Jan 21, 2020·14 cites·28 claims
- 0387US11826416B2Induce and enhance immune responses using recombinant replicon systemsJANSSEN PHARMACEUTICALS INC·Filed 2021·Granted Nov 28, 2023·1 cites·24 claims
- 0487US11730804B1Compositions and methods for the prevention and treatment of rabies virus infectionREPLICATE BIOSCIENCE INC·Filed 2022·Granted Aug 22, 2023·1 cites·26 claims
- 0581US11510975B1Compositions and methods for inducing ESR1, PI3K, HER2, and HER3 immune responsesREPLICATE BIOSCIENCE INC·Filed 2021·Granted Nov 29, 2022·1 cites·30 claims
- 0679US12460229B2Recombinant arterivirus replicon systems and uses thereofJANSSEN PHARMACEUTICALS INC·Filed 2023·Granted Nov 4, 2025·0 cites·1 claims
- 0777US12083223B2Nanolipoprotein particles and related compositions methods and systems for loading RNAL LIVERMORE NAT SECURITY LLC·Filed 2018·Granted Sep 10, 2024·1 cites·52 claims
- 0876US2024042005A1Induce and enhance immune responses using recombinant replicon systemsJANSSEN PHARMACEUTICALS INC·Filed 2023·Application pending·0 cites
- 0975US2024209379A1Compositions and methods for enhancing gene expressionJANSSEN PHARMACEUTICALS INC·Filed 2023·Application pending·0 cites
- 1070US11555205B2Recombinant arterivirus replicon systems and uses thereofJANSSEN PHARMACEUTICALS INC·Filed 2019·Granted Jan 17, 2023·0 cites·17 claims
- 1170US2024207186A1Nanolipoprotein particles and related compositions methods and systems for loading rnaL LIVERMORE NAT SECURITY LLC·Filed 2024·Application pending·0 cites
- 1270US2025186574A1Compositions and methods for the prevention and treatment of rabies virus infectionREPLICATE BIOSCIENCE INC·Filed 2023·Application pending·0 cites
- 1362US2025146038A1Methods for generating functional self-replicating rna moleculesREPLICATE BIOSCIENCE INC·Filed 2023·Application pending·0 cites
- 1461US2025257329A1Modified western equine encephalitis viruses and uses thereofREPLICATE BIOSCIENCE INC·Filed 2023·Application pending·0 cites
- 1560US11845939B2Compositions and methods for enhancing gene expressionJANSSEN PHARMACEUTICALS INC·Filed 2017·Granted Dec 19, 2023·0 cites·50 claims
- 1660US2024400619A1Modified alphaviruses with heterologous nonstructural proteinsREPLICATE BIOSCIENCE INC·Filed 2022·Application pending·0 cites
- 1760US2025019745A1Methods of generating self-replicating rna moleculesREPLICATE BIOSCIENCE INC·Filed 2022·Application pending·0 cites
- 1860US2025027110A1Compositions and methods for inducing esr1, pi3k, her2, and her3 immune responsesREPLICATE BIOSCIENCE INC·Filed 2022·Application pending·0 cites
- 1958US2024218395A1Alphavirus vectors containing universal cloning adaptorsREPLICATE BIOSCIENCE INC·Filed 2022·Application pending·0 cites
- 2058US2024327865A1Modified eastern equine encephalitis viruses, self-replicating rna constructs, and uses thereofREPLICATE BIOSCIENCE INC·Filed 2022·Application pending·0 cites
- 2157US2025027109A1Compositions and methods for expression of il-12 and il-1raREPLICATE BIOSCIENCE INC·Filed 2022·Application pending·0 cites
- 2256US11873507B2Compositions and methods for expression of IL-12 and IL-1RAREPLICATE BIOSCIENCE INC·Filed 2021·Granted Jan 16, 2024·0 cites·19 claims
- 2355US2023398200A1Modified chikungunya viruses and sindbis viruses and uses thereofREPLICATE BIOSCIENCE INC·Filed 2021·Application pending·0 cites
- 2452US2022016237A1Rna replicon vaccines against hbvJANSSEN SCIENCES IRELAND UNLIMITED CO·Filed 2021·Application pending·0 cites
- 2551US12331076B2Alphavirus-based replicons for administration of biotherapeuticsJANSSEN PHARMACEUTICALS INC·Filed 2019·Granted Jun 17, 2025·0 cites·20 claims
Join the waitlist — get patent alerts
Get an alert when Nathaniel Stephen Wang files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →